重组溶瘤性兔病毒性出血症病毒的构建方法。
Methods for the Construction of Recombinant Oncolytic Myxoma Viruses.
机构信息
Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, Arizona State University, Tempe, AZ, USA.
Department of Molecular Genetics and Microbiology, University of Florida, Gainesville, FL, USA.
出版信息
Methods Mol Biol. 2021;2225:63-75. doi: 10.1007/978-1-0716-1012-1_4.
Abstract
Myxoma virus (MYXV) has proven to be an effective candidate for oncolytic virotherapy in many preclinical cancer models. As a nonhuman pathogen, MYXV does not need to overcome any preexisting antiviral immunity, and its DNA cannot integrate into the host genome, making it an extremely safe vector. Moreover, the large dsDNA genome of MYXV allows the insertion of multiple transgenes and the design of engineered recombinant oncolytic viruses (OVs) with enhanced immunostimulatory or other desired properties. In this chapter, we describe detailed protocols for the generation and characterization of transgene-armed recombinant MYXV vectors.
摘要
粘液瘤病毒（MYXV）已被证明是许多临床前癌症模型中溶瘤病毒治疗的有效候选者。作为一种非人类病原体，MYXV 不需要克服任何预先存在的抗病毒免疫，并且其 DNA 不能整合到宿主基因组中，使其成为一种极其安全的载体。此外，MYXV 的大型 dsDNA 基因组允许插入多个转基因，并设计具有增强的免疫刺激性或其他所需特性的工程重组溶瘤病毒（OV）。在本章中，我们描述了携带转基因的重组 MYXV 载体的生成和表征的详细方案。
相似文献
1
Methods for the Construction of Recombinant Oncolytic Myxoma Viruses.重组溶瘤性兔病毒性出血症病毒的构建方法。
Methods Mol Biol. 2021;2225:63-75. doi: 10.1007/978-1-0716-1012-1_4.
2
Recombinant Myxoma Virus Expressing Walleye Dermal Sarcoma Virus orfC Is Attenuated in Rabbits.表达美洲红点鲑疱疹病毒 orfC 的重组兔粘液瘤病毒在兔子中减毒。
Viruses. 2020 May 8;12(5):517. doi: 10.3390/v12050517.
3
Production of Myxoma virus gateway entry and expression libraries and validation of viral protein expression.黏液瘤病毒网关入门和表达文库的构建及病毒蛋白表达的验证
Curr Protoc Microbiol. 2011 May;Chapter 14:Unit 14A.2. doi: 10.1002/9780471729259.mc14a02s21.
4
Ex Vivo Virotherapy with Myxoma Virus to Treat Cancer.利用黏液瘤病毒进行离体病毒疗法治疗癌症。
Methods Mol Biol. 2020;2058:95-110. doi: 10.1007/978-1-4939-9794-7_6.
5
RNA Helicase A/DHX9 Forms Unique Cytoplasmic Antiviral Granules That Restrict Oncolytic Myxoma Virus Replication in Human Cancer Cells.RNA 解旋酶 A/DHX9 形成独特的细胞质抗病毒颗粒，限制溶瘤性兔病毒性出血热病毒在人癌细胞中的复制。
J Virol. 2021 Jun 24;95(14):e0015121. doi: 10.1128/JVI.00151-21.
6
In vitro screen of a small molecule inhibitor drug library identifies multiple compounds that synergize with oncolytic myxoma virus against human brain tumor-initiating cells.小分子抑制剂药物文库的体外筛选鉴定出多种与溶瘤黏液瘤病毒协同作用对抗人脑肿瘤起始细胞的化合物。
Neuro Oncol. 2015 Aug;17(8):1086-94. doi: 10.1093/neuonc/nou359. Epub 2015 Jan 20.
7
Oncolytic myxoma virus: the path to clinic.溶瘤性牛痘病毒：走向临床的道路。
Vaccine. 2013 Sep 6;31(39):4252-8. doi: 10.1016/j.vaccine.2013.05.056. Epub 2013 May 29.
8
Poxviruses as Gene Therapy Vectors: Generating Poxviral Vectors Expressing Therapeutic Transgenes.痘病毒作为基因治疗载体：构建表达治疗性转基因的痘病毒载体
Methods Mol Biol. 2019;1937:189-209. doi: 10.1007/978-1-4939-9065-8_11.
9
Myxoma virus expressing interleukin-15 fails to cause lethal myxomatosis in European rabbits.表达白细胞介素-15的黏液瘤病毒无法在欧洲兔中引发致命的黏液瘤病。
J Virol. 2009 Jun;83(11):5933-8. doi: 10.1128/JVI.00204-09. Epub 2009 Mar 11.
10
Inducible gene expression in tumors colonized by modified oncolytic vaccinia virus strains.肿瘤中经修饰的溶瘤痘苗病毒株感染后诱导基因表达。
J Virol. 2014 Oct;88(19):11556-67. doi: 10.1128/JVI.00681-14. Epub 2014 Jul 23.
引用本文的文献
1
Dual-Armed Oncolytic Myxoma Virus Encoding IFN-γ and CD47 Promotes Lymphocyte Infiltration and Tumor Suppression of Syngeneic Murine Melanoma.编码干扰素-γ和CD47的双武装溶瘤黏液瘤病毒促进同基因小鼠黑色素瘤的淋巴细胞浸润和肿瘤抑制
Cancers (Basel). 2023 Sep 24;15(19):4703. doi: 10.3390/cancers15194703.
2
Combination of LIGHT (TNFSF14)-Armed Myxoma Virus Pre-Loaded into ADSCs and Gemcitabine in the Treatment of Experimental Orthotopic Murine Pancreatic Adenocarcinoma.预加载到脂肪干细胞中的 LIGHT（肿瘤坏死因子配体超家族成员14）武装黏液瘤病毒与吉西他滨联合治疗实验性原位小鼠胰腺腺癌
Cancers (Basel). 2022 Apr 16;14(8):2022. doi: 10.3390/cancers14082022.
3
Myxoma Virus Expressing LIGHT (TNFSF14) Pre-Loaded into Adipose-Derived Mesenchymal Stem Cells Is Effective Treatment for Murine Pancreatic Adenocarcinoma.预先加载到脂肪来源间充质干细胞中的表达LIGHT（肿瘤坏死因子配体超家族成员14）的黏液瘤病毒是治疗小鼠胰腺腺癌的有效方法。
Cancers (Basel). 2021 Mar 19;13(6):1394. doi: 10.3390/cancers13061394.
本文引用的文献
1
Oncolytic Virotherapy with Myxoma Virus.黏液瘤病毒溶瘤病毒疗法
J Clin Med. 2020 Jan 8;9(1):171. doi: 10.3390/jcm9010171.
2
Poxvirus oncolytic virotherapy.痘病毒溶瘤病毒疗法。
Expert Opin Biol Ther. 2019 Jun;19(6):561-573. doi: 10.1080/14712598.2019.1600669. Epub 2019 Apr 4.
3
Methods for Identifying Virus-Derived Serpins.鉴定病毒衍生丝氨酸蛋白酶抑制剂的方法
Methods Mol Biol. 2018;1826:73-86. doi: 10.1007/978-1-4939-8645-3_5.
4
Genetically Engineered Vaccinia Viruses As Agents for Cancer Treatment, Imaging, and Transgene Delivery.基因工程痘苗病毒作为癌症治疗、成像及转基因递送的载体
Front Oncol. 2017 May 23;7:96. doi: 10.3389/fonc.2017.00096. eCollection 2017.
5
Tumor-Localized Secretion of Soluble PD1 Enhances Oncolytic Virotherapy.肿瘤局部可溶性PD1的分泌增强溶瘤病毒疗法。
Cancer Res. 2017 Jun 1;77(11):2952-2963. doi: 10.1158/0008-5472.CAN-16-1638. Epub 2017 Mar 17.
6
Talimogene laherparepvec (T-VEC) as cancer immunotherapy.塔利莫基因拉罗韦克（T-VEC）作为癌症免疫疗法。
Drugs Today (Barc). 2015 Sep;51(9):549-58. doi: 10.1358/dot.2015.51.9.2383044.
7
Multiple Immunoblots by Passive Diffusion of Proteins from a Single SDS-PAGE Gel.通过蛋白质从单一SDS-PAGE凝胶的被动扩散进行多次免疫印迹分析。
Methods Mol Biol. 2015;1312:77-86. doi: 10.1007/978-1-4939-2694-7_11.
8
Oncolytic Poxviruses.溶瘤痘病毒
Annu Rev Virol. 2014 Sep 1;1(1):119-141. doi: 10.1146/annurev-virology-031413-085442.
9
Myxoma virus expressing a fusion protein of interleukin-15 (IL15) and IL15 receptor alpha has enhanced antitumor activity.表达白细胞介素-15（IL15）和IL15受体α融合蛋白的黏液瘤病毒具有增强的抗肿瘤活性。
PLoS One. 2014 Oct 16;9(10):e109801. doi: 10.1371/journal.pone.0109801. eCollection 2014.
10
Immunotherapeutic potential of oncolytic vaccinia virus.溶瘤痘苗病毒的免疫治疗潜力。
Front Oncol. 2014 Jun 17;4:155. doi: 10.3389/fonc.2014.00155. eCollection 2014.
Zotero 插件